Concepedia

Sara Sigler

SS

Statistics

Publications

4

Citations

163

H-Index

4

Active since

2011

Affiliations

University of South Alabama(Current)

USA Mitchell Cancer Institute

Incell Corporation (United States)

Southern Research Institute

University of Alabama at Birmingham

Sara Sigler is an author at University of South Alabama specializing in colorectal cancer, pharmacology, and oncogenic signaling pathways.

Publications per year

2011–2021

4

Publications

4

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity

Nailin Li, Kyongbum Lee, Yaguang Xi et al. · Oncogene · 2014 · 72 citations · Full text

, , +14

Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10

Nan Li, Xi Chen, Bing Zhu et al. · Oncotarget · 2015 · 53 citations · Full text

, , +16

From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity

Mohammad Abdel‐Halim, Sara Sigler, Nora A. S. Racheed et al. · Journal of Medicinal Chemistry · 2021 · 24 citations · Full text

, , +15

Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanism

Xiaozhen Yu, Sara Sigler, Delwar Hossain et al. · Journal of Molecular Modeling · 2011 · 14 citations · Full text

, , +16

1–4 of 4